Aakaar Medical Technologies Ltd
₹ 86.0
-1.15%
31 Oct
- close price
About
Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices.[1]
Key Points
- Market Cap ₹ 122 Cr.
- Current Price ₹ 86.0
- High / Low ₹ 105 / 62.0
- Stock P/E 20.2
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 26.7 %
- ROE 33.8 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 27.0% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 29.2%
Cons
- Promoter holding has decreased over last quarter: -24.1%
- Company has high debtors of 166 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Upcoming result date: 10 November 2025
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 22.89 | 12.44 | 19.47 | 32.78 | 46.11 | 61.58 | |
| 20.01 | 11.54 | 17.07 | 29.25 | 41.11 | 51.84 | |
| Operating Profit | 2.88 | 0.90 | 2.40 | 3.53 | 5.00 | 9.74 |
| OPM % | 12.58% | 7.23% | 12.33% | 10.77% | 10.84% | 15.82% |
| 0.12 | 0.12 | 0.04 | 0.09 | 0.16 | 0.18 | |
| Interest | 0.46 | 0.23 | 0.21 | 0.43 | 1.14 | 1.71 |
| Depreciation | 0.04 | 0.03 | 0.02 | 0.09 | 0.14 | 0.12 |
| Profit before tax | 2.50 | 0.76 | 2.21 | 3.10 | 3.88 | 8.09 |
| Tax % | 26.80% | 28.95% | 26.24% | 30.65% | 26.29% | 25.22% |
| 1.83 | 0.54 | 1.62 | 2.15 | 2.87 | 6.04 | |
| EPS in Rs | 183.00 | 54.00 | 23.14 | 30.71 | 41.00 | 5.80 |
| Dividend Payout % | 0.00% | 0.00% | 34.57% | 24.42% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 47% |
| TTM: | 34% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 27% |
| 3 Years: | 55% |
| TTM: | 110% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 29% |
| Last Year: | 34% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.10 | 0.10 | 0.70 | 0.70 | 0.70 | 10.42 |
| Reserves | 6.75 | 7.30 | 7.33 | 8.96 | 11.84 | 12.78 |
| 5.88 | 3.88 | 3.82 | 5.87 | 15.05 | 22.74 | |
| 3.56 | 3.03 | 6.15 | 7.70 | 6.42 | 8.17 | |
| Total Liabilities | 16.29 | 14.31 | 18.00 | 23.23 | 34.01 | 54.11 |
| 0.06 | 0.04 | 0.20 | 0.36 | 0.28 | 0.24 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.47 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| 15.76 | 14.16 | 17.80 | 22.87 | 33.73 | 53.87 | |
| Total Assets | 16.29 | 14.31 | 18.00 | 23.23 | 34.01 | 54.11 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -0.38 | 4.31 | 0.48 | -2.93 | -8.04 | -5.41 | |
| 0.10 | 0.37 | -0.23 | -0.32 | -0.04 | -0.05 | |
| 0.28 | -2.00 | -0.81 | 1.17 | 8.19 | 10.71 | |
| Net Cash Flow | 0.00 | 2.68 | -0.55 | -2.08 | 0.11 | 5.25 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 117.84 | 135.85 | 104.42 | 113.91 | 128.71 | 165.96 |
| Inventory Days | 234.33 | 366.16 | 281.70 | 273.75 | 247.29 | 202.47 |
| Days Payable | 28.20 | 98.96 | 65.19 | 61.56 | 31.74 | 48.84 |
| Cash Conversion Cycle | 323.97 | 403.05 | 320.92 | 326.10 | 344.26 | 319.59 |
| Working Capital Days | 189.44 | 238.25 | 105.17 | 101.55 | 93.96 | 96.85 |
| ROCE % | 8.25% | 20.93% | 25.79% | 23.28% | 26.66% |
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
31 October 2025 - Earnings call on Nov 10, 2025 at 4:00 PM IST after unaudited H1FY25-26 results for period ended Sep 30, 2025.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
10 October 2025 - Registrar certifies Regulation 74(5) non-applicable for quarter ended Sept 30, 2025; all shares in demat form.
-
Analysts/Institutional Investor Meet/Con. Call Updates
10 October 2025 - Audio and video recording of investor meet on 09-Oct-2025 published on company website (link provided).
-
Analysts/Institutional Investor Meet/Con. Call Updates
3 October 2025 - Investor meeting on 09.10.2025 at 4:00 PM IST online (Aakaar Medical Technologies).
-
Analysts/Institutional Investor Meet/Con. Call Updates
3 October 2025 - Investor group meeting on 09-10-2025 at 16:00 IST, online; no UPSI.
Business Profile[1]
Aakaar Medical Technologies operates in the medical aesthetics segment, offering a portfolio of aesthetic products and devices through a B2B model. It caters primarily to dermatologists, plastic surgeons, and aesthetic physicians across India.